123 related articles for article (PubMed ID: 10221068)
1. [Clinical trial of the month. The CIBIS-II study].
Kulbertus H
Rev Med Liege; 1999 Feb; 54(2):128-9. PubMed ID: 10221068
[TBL] [Abstract][Full Text] [Related]
2. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.
Lancet; 1999 Jan; 353(9146):9-13. PubMed ID: 10023943
[TBL] [Abstract][Full Text] [Related]
3. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).
Böhm M; Maack C; Wehrlen-Grandjean M; Erdmann E
Z Kardiol; 2003 Aug; 92(8):668-76. PubMed ID: 12955414
[TBL] [Abstract][Full Text] [Related]
4. Bisoprolol: a review of its use in chronic heart failure.
McGavin JK; Keating GM
Drugs; 2002; 62(18):2677-96. PubMed ID: 12466013
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of the efficacy of bisoprolol administration by cardiopulmonary exercise testing in patients with heart failure].
Terzi S; Dayi SU; Akbulut T; Dağ O; Köse H; Satiroğlu O; Sayar N; Bilsel T; Aksoy S; Yeşilçimen K
Anadolu Kardiyol Derg; 2003 Dec; 3(4):313-8. PubMed ID: 14675880
[TBL] [Abstract][Full Text] [Related]
6. Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: results of CIBIS II.
Krum H; Bailey M; Meyer W; Verkenne P; Dargie H; Lechat P; Anker S
Cardiology; 2007; 108(1):28-34. PubMed ID: 16960445
[TBL] [Abstract][Full Text] [Related]
7. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
Funck-Brentano C; van Veldhuisen DJ; van de Ven LL; Follath F; Goulder M; Willenheimer R;
Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.
Circulation; 1994 Oct; 90(4):1765-73. PubMed ID: 7923660
[TBL] [Abstract][Full Text] [Related]
9. Effect on mode of death of heart failure treatment started with bisoprolol followed by Enalapril, compared to the opposite order: results of the randomized CIBIS III trial.
Krum H; van Veldhuisen DJ; Funck-Brentano C; Vanoli E; Silke B; Erdmann E; Follath F; Ponikowski P; Goulder M; Meyer W; Lechat P; Willenheimer R;
Cardiovasc Ther; 2011 Apr; 29(2):89-98. PubMed ID: 20528880
[TBL] [Abstract][Full Text] [Related]
10. Design of the cardiac insufficiency bisoprolol study II (CIBIS II). The CIBIS II Scientific Committee.
Fundam Clin Pharmacol; 1997; 11(2):138-42. PubMed ID: 9107560
[TBL] [Abstract][Full Text] [Related]
11. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
[TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized, double-blind, placebo controlled trial of beta-blockade in patients who have undergone surgical correction of tetralogy of Fallot.
Norozi K; Bahlmann J; Raab B; Alpers V; Arnhold JO; Kuehne T; Klimes K; Zoege M; Geyer S; Wessel A; Buchhorn R
Cardiol Young; 2007 Aug; 17(4):372-9. PubMed ID: 17572925
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of the month. The MERIT-HF study].
Kulbertus H
Rev Med Liege; 1999 Jul; 54(7):623-4. PubMed ID: 10495686
[TBL] [Abstract][Full Text] [Related]
14. [Clinical, hemodynamic and neurohumoral effects of long-term therapy of patients with severe chronic heart failure with beta-adrenoblocker bisoprolol].
Belenkov IuN; Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Narusov OIu; Baklanova NA; Masenko VP
Kardiologiia; 2003; 43(10):10-21. PubMed ID: 14593351
[TBL] [Abstract][Full Text] [Related]
15. [The use of beta blockers in heart failure: clinical studies].
Cobelli F
Ital Heart J Suppl; 2000 Aug; 1(8):996-1002. PubMed ID: 10993005
[TBL] [Abstract][Full Text] [Related]
16. CIBIS III trial: Bisoprolol treatment for CHF leads to 46% reduction in sudden death after one year.
Cardiovasc J S Afr; 2006; 17(5):278. PubMed ID: 17117242
[No Abstract] [Full Text] [Related]
17. [Chronic heart failure and sudden death: the message of CIBIS-III].
Dequarti MC; Poggio L; Vanoli E
Recenti Prog Med; 2007 Dec; 98(12):638-45. PubMed ID: 18369041
[TBL] [Abstract][Full Text] [Related]
18. The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.
Wikstrand J; Wedel H; Castagno D; McMurray JJ
J Intern Med; 2014 Feb; 275(2):134-43. PubMed ID: 24118421
[TBL] [Abstract][Full Text] [Related]
19. Using Cardicor as first-line therapy in heart failure : CiBis iii.
Cardiovasc J Afr; 2009; 20(1):78. PubMed ID: 19382368
[No Abstract] [Full Text] [Related]
20. Predictors of medical events in patients enrolled in the cardiac insufficiency bisoprolol study (CIBIS): a study of the interactions between beta-blocker therapy and occurrence of critical events using analysis of competitive risks.
Funck-Brentano C; Lancar R; Le Heuzey JY; Lardoux H; Soubrié C; Lechat P
Am Heart J; 2000 Feb; 139(2 Pt 1):262-71. PubMed ID: 10650299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]